Genoxy

Company Overview

Snapshot

Founded in January 2021 by Ronen Sobel, Genoxy operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its patented technology.

Business overview

Genoxy is developing a patented, natural, and non-toxic method for disinfecting drug-resistant bacteria from surfaces. Its core technology involves the bio-conversion of water into hydrogen peroxide, delivered via a desktop convertor with a jet technology hand piece that breaks liquid into micro-droplets for complete surface coverage without wiping. The company aims to serve the healthcare industry by enhancing public safety and improving supply chain efficiency through reduced material and labor costs, operating within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Genoxy's primary technological focus?

Genoxy is focused on developing a patented, natural, and non-toxic method for eliminating antibiotic-resistant bacteria from surfaces through the bio-conversion of water into hydrogen peroxide.

When was Genoxy founded and by whom?

Genoxy was founded in January 2021 by Ronen Sobel, who serves as Co-founder & CEO.

What is the current stage of Genoxy's product development?

Genoxy's product, which includes a desktop convertor and jet technology hand piece, is currently in the R&D stage.

What markets does Genoxy aim to serve?

Genoxy aims to serve the healthcare market, specifically targeting hospitals and medical device applications, with a focus on public safety and operational efficiency.

What is Genoxy's business model?

Genoxy operates on a B2B business model, providing its disinfection technology to other businesses and organizations.